Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer Genomics and Diagnostics, and HER2/EGFR in Cancer Research.
Mucin-producing breast lesions: a practical approach to diagnosis.
World Health Organization classification of tumours of the breast 6th edition 2026.
Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.
Lung Carcinoma Metastatic to the Breast: A Comprehensive Analysis of Clinical Presentation, Morphologic, and Molecular Features, With Emphasis on Diagnostic Pitfalls
Malignant phyllodes tumours of the breast: the case for revising <scp>WHO’</scp>s ‘full house’ diagnostic criteria
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.
Frank Invasion in Tall Cell Carcinoma With Reversed Polarity of the Breast: Report of Two Cases
Discordance of human epidermal growth factor receptor 2-low status between breast primary and distant metastases with clinical-pathological correlation.
Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis.
Variability in the diagnosis and reporting of metaplastic breast carcinoma: results of an international survey.
Clinicopathological features of microinvasive lobular carcinoma.
Microinvasive carcinoma of the breast
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms.
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.
Supplementary Data from A Genomics-Driven Artificial Intelligence<b>–</b>Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers <i>CDH1</i> Inactivating Mechanisms
Data from A Genomics-Driven Artificial Intelligence<b>–</b>Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers <i>CDH1</i> Inactivating Mechanisms
Discordance of HER2-low Status between Breast Primary and Distant Metastases with Clinical-pathological Correlation
Invasive Disease Free Survival and Brain Metastasis Rates in Patients Treated with Neoadjuvant Chemotherapy with Trastuzumab and Pertuzumab
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations.
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.
Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners.
Deep Multi-Magnification Networks for multi-class breast cancer image segmentation
Deep Multi-Magnification Networks for multi-class breast cancer image segmentation
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma.